a-d MTT assay showing the overall viability of the cancer cells ectopically expressed with MAGEA3 in compared to control cells (a and b) and that of BxPC3 cells depleted with MAGEA3 (c and d) in response to autophagic conditions (0% FBS, 0% FBS+ Rapamycin, 0% FBS + BafilomycinA1, 0% FBS + Torin2, 0% FBS + Wortmanin). The gene discussed is MAGEA3; the disease is cancer.